ArticleFrontiers in oncology2025

Case Report: Navigating novel therapies and systemic barriers in ovarian clear cell carcinoma through a complete response to lenvatinib, pembrolizumab, and SFRT.

Jared Hobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.